Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development
Abstract Recent evidence suggested that the mRNA vaccine has been effective for many tumors, but its progress in gliomas was slow. In this study, we screened potential tumor antigens and suitable populations for mRNA vaccine to develop mRNA vaccine for glioma. We integrated the normalized RNA sequen...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2022-07-01
|
| Edice: | Cancer Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/cam4.4633 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|